StrainX is a biotechnology company utilizing synthetic biology and precision fermentation to produce high-value, sustainable ingredients for food, nutraceutical, and personal care markets through an integrated, scalable manufacturing platform.
StrainX Bioworks is an Indian biotechnology startup specializing in synthetic biology and precision fermentation. The company has developed an integrated in-house platform that spans strain engineering, fermentation processes, scale-up, and product development. By engineering microorganisms to produce high-value biomolecules, StrainX creates sustainable, ethical, and high-performance ingredients tailored for the global food, nutraceutical, and personal care markets. The company operates a modular manufacturing facility in Bhopal, India, with verified 10,000-liter fermentation capabilities and a strategic design path to reach 100,000-liter capacity to achieve competitive cost advantages in bio-based production.
This technology is significant for customers and partners seeking clean-label, scalable alternatives to traditional ingredients, addressing global demands for sustainable nutrition and material production. StrainX has demonstrated operational maturity by securing US self-GRAS status for an ingredient and conducting trials with numerous food and beverage companies. With a workforce of over 100 experts, the startup is leveraging India’s scientific infrastructure and cost-effective manufacturing capabilities to position itself as a global leader in the synthetic biology sector, supported by significant venture capital investment.